AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glemallit-GM2 Tablet SR

Prescription Icon
Prescription Required

Marketer

Allito Biocare

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glemallit-GM2 Tablet SR

Diabeticard Duo SR tablets are a dual-action antidiabetic medication prescribed for adult patients with type 2 diabetes. This combination therapy helps regulate blood glucose. Diabeticard Duo SR should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical supervision can elevate glucose levels, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication forms part of a comprehensive diabetes management plan that includes a balanced diet, regular physical activity, and weight management as recommended by your doctor. Lifestyle choices significantly impact diabetes control. The primary adverse effect is hypoglycemia (low blood sugar), manifested by symptoms such as sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are essential to mitigate this risk. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is a possibility for some patients. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating women should seek medical advice prior to use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to assess blood cell counts and liver function.

Primary Ingredients of Glemallit-GM2 Tablet SR

No information provided. Please provide the text you wish to be rewritten.

Uses of Glemallit-GM2 Tablet SR

Managing type 2 diabetes

Major Benefits of Glemallit-GM2 Tablet SR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glemallit-GM2 Tablet SR whole; do not fracture, pulverize, or chew it. Administer this medication with a meal.

Common Side effects of Glemallit-GM2 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glemallit-GM2 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glemallit-GM2 Tablet SR. Ingest the tablet whole; avoid crushing, chewing, or breaking it. Administer this medication with a meal.

How Glemallit-GM2 Tablet SR works:

Glemallit-GM2 SR tablets contain a dual-action antidiabetic formula: glimepiride and metformin. Glimepiride, a sulfonylurea agent, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts through a threefold mechanism: decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glemallit-GM2 Tablet SR and alcohol is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glemallit-GM2 Tablet SR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing this medication. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glemallit-GM2 tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glemallit-GM2 Tablet SR cautiously, potentially requiring dosage modification. Consult a physician before use. Glemallit-GM2 Tablet SR is contraindicated in those with severe kidney disease. Regular monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glemallit-GM2 Tablet SR cautiously, potentially requiring dosage modification. Consultation with a physician is advised. A low initial dose is typically prescribed for those with mild to moderate hepatic dysfunction; however, Glemallit-GM2 Tablet SR is contraindicated in patients exhibiting severe liver disease.

What if you forget to take Glemallit-GM2 Tablet SR :

Should you forget a Glemallit-GM2 Tablet SR dose, take it immediately. If, however, your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Glemallit-GM2 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glemallit-GM2 Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glemallit-GM2 Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms may include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glemallit-GM2 Tablet SR and seek immediate medical attention.
Glemallit-GM2 SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This medication improves blood sugar control when used with a healthy diet and regular exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This combination is unsuitable for treating type 1 diabetes.
Glemallit-GM2 Tablet SR may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged Glemallit-GM2 Tablet SR use can lead to vitamin B12 deficiency by impairing its stomach absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glemallit-GM2 Tablet SR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glemallit-GM2 Tablet SR and alcohol is unsafe. Alcohol can worsen the medication's blood sugar-lowering effects, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Glemallit-GM2 Tablet SR
56
MRP 65
13% off